Breast Cancer Breakthroughs

Through our investment in BREAST-PREDICT, the Irish Cancer Society’s collaborative breast cancer research centre, Irish cancer researchers have made real progress in the race to stop breast cancer. 
 
Since 2013 the Irish Cancer Society has invested €7.5 million into BREAST-PREDICT, a five-year initiative where breast cancer researchers from across the country work together to find better ways to prevent, detect, and treat the disease in all its forms. They also look at ways in which breast cancer survivors can live long and better quality lives after their diagnosis.
 
Because of the public's support for the Irish Cancer Society, we've been able to fund research that has the potential to make a lasting difference to the lives of breast cancer patients in Ireland and across the world for generations to come. Here are some of BREAST-PREDICT's success stories so far:
 

 

Irish Cancer Society researchers discover potential new way to treat aggressive type of breast cancer

Research led by BREAST-PREDICT scientists based in UCD and RCSI has found a potential new approach to treating triple negative breast cancer. This is one of the most difficult-to-treat forms of breast cancer. Read more.

 

 

Potential new treatment for ER-positive breast cancer patients

BREAST-PREDICT researcher Prof Leonie Young and Dr Sara Charmsaz have found a new way to monitor the treatment of Estrogen receptor-positive (ER-positive) breast cancer patients. Read more.

 

 

Potential treatment options discovered for advanced breast cancer patients

A new finding by researchers funded by the Irish Cancer Society, including Dr Damir Vareslija, gives hope for breast cancer patients whose cancer has spread to the brain. Read more